Overview
- Description
The company is in Phase 2 clinical trials with their innovative anti-inflammatory macrolide-derived molecules, targeting COPD and other respiratory diseases.
- Website
- Country
- Iceland
- Sector
- Health Biotechnology
EpiEndo Pharmaceuticals
First-in-class disease-modifying drug for chronic airway disorders